Avraham Ben-Tzvi - 23 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role: Director
Signature: /s/ Avraham Ben-Tzvi
Issuer symbol: INDP
Transactions as of: 23 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 22 Jan 2026, 21:57:06 UTC
Previous filing: 23 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ben-Tzvi Avraham	Director	44 ZAYT SHEMEN ST., FLAT 4, EFRAT, ISRAEL	/s/ Avraham Ben-Tzvi	22 Jan 2026	0001944721

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INDP	Common Stock	Award	$0	+25,000	+25000%	$0.000000	25,100	20 Jan 2026	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INDP	Option to Buy Common Stock	Award	$0	+25,000		$0.000000	25,000	23 Dec 2025	Common Stock	25,000	$1.95	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person acquired 25,000 shares of restricted common stock of the Issuer pursuant to a consulting agreement dated January 20, 2026, which shares vested 100% upon grant.
F2	Includes 100 shares of common stock of the Issuer held in a Roth IRA.
F3	The Reporting Person acquired options to purchase 25,000 shares of common stock pursuant to the Issuer's non-employee director compensation program. The stock options vest over three years commencing from the date of grant in equal quarterly installments subject to continued service on the Board through each vesting date.